Sotac Pharmaceuticals Limited is an India-based pharmaceutical company. The Company's services include contract manufacturing, loan license, formulation and development (F & D) and research and development (R & D). It specializes in manufacturing a range of pharmaceutical products having a therapeutic portfolio including anti-diabetic, anti-psychotic, vitamins, minerals, iron, anti-cold, anti-allergic, dermatological products, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics (IP-Lactams & Non-IP-Lactams), anti-fungal and cephalosporin. It also manufactures nutraceuticals products and food products on contract-manufacturing basis. Its products are supplied across 14 states in India, and it exports its products to over 20 countries worldwide. Its subsidiaries include Sotac Healthcare Private Limited, Sotac Lifesciences Private Limited and Sotac Research Private Limited.As of 26 May 2026, SOTAC PHARMACEUTICALS LTD share price is ₹111.00. The stock opened at ₹111.00, compared to its previous close of ₹111.30. During today's trading session, SOTAC PHARMACEUTICALS LTD share price moved in the range of ₹111.00 to ₹111.00, with an average price of ₹111.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹111.00 and a high of ₹111.00. On the performance front, SOTAC PHARMACEUTICALS LTD share price has declined by 9.42% over the last six months and is down 7.81% on a year-on-year basis.
The market capitalization of SOTAC PHARMACEUTICALS LTD is ₹123 Crs, with a P/E ratio of 16.4 and a dividend yield of 0.00%.